Feng Ye, Tian Gao, Lu Xie, Chaoyang Wu, Li Min, Kai Yang. "Phase Ib trial of C019199, an oral TME modulator targeting CSF-1R/DDRs/VEGFR2, in relapsed or refractory osteosarcoma.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.11510